Novel Insights into Autoimmune/Autoinflammatory Skin Diseases

A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".

Deadline for manuscript submissions: 30 September 2024 | Viewed by 1677

Special Issue Editors


E-Mail Website
Guest Editor
1. Department of Pathophysiology and Transplantation, Università Degli Studi di Milano, Milan, Italy
2. Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico Milano, Milan, Italy
Interests: neutrophilic dermatoses, including pyoderma gangrenosum, sweet syndrome, and amicrobial pustulosis of the folds; autoinflammatory skin diseases; hidradenitis suppurativa; autoimmune bullous dermatoses; connective tissue diseases; chronic urticaria; atopic dermatitis; psoriasis
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Dermatology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy
Interests: clinical or molecular genetics and immunobiology of autoimmune and autoinflammatory skin disorders including, among others, hidradenitis suppurativa and pyoderma gangrenosum; genetics of infectious diseases; genodermatoses
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Over the past few decades, new -omic approaches, such as Genome-Wide Association Studies (GWAS), Whole-Exome Sequencing (WES), transcriptomics and proteomics, metabolomics, etc., have allowed researchers to identify novel causative genetic variants and biological signaling pathways that contribute to the susceptibility and severity of several skin disorders. Therefore, Next-Generation Sequencing (NGS) analyses, in combination with bioinformatics pipelines, enabled researchers to employ a more comprehensive approach to unravelling the complex aetiology of skin diseases, such as atopic dermatitis, psoriasis, pyoderma gangrenosum and hidradenitis suppurativa, thus, allowing for the translation of the -omic findings to diagnosis and patient follow-up.

Despite this, the pathophysiology of these autoimmune/autoinflammatory skin diseases has not been fully elucidated and a clear genotype–phenotype correlation is still to be improved.

The aim of this Special Issue is to inspire the community by exploring new approaches and perspectives on the mechanisms underlying autoimmune/autoinflammatory skin diseases and potential therapeutic targets for personalized medicine.

We encourage researchers in the field of -omics applied to autoimmune/autoinflammatory skin diseases to contribute with original articles, reviews and communications on the pathophysiology of these skin diseases, needing more data to be fully understood in favor of patient-tailored treatment.

Prof. Dr. Angelo Valerio Marzano
Prof. Dr. Sergio Crovella
Dr. Chiara Moltrasio
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • autoimmune/autoinflammatory skin diseases
  • omics
  • bioinformatics
  • pathogenesis
  • tailored medicine

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

14 pages, 1009 KiB  
Review
Therapeutic Potential of IL-1 Antagonism in Hidradenitis Suppurativa
by Laura Calabrese, Dalma Malvaso, Giulia Coscarella, Flaminia Antonelli, Alessandra D’Amore, Niccolò Gori, Pietro Rubegni, Ketty Peris and Andrea Chiricozzi
Biomolecules 2024, 14(2), 175; https://0-doi-org.brum.beds.ac.uk/10.3390/biom14020175 - 01 Feb 2024
Viewed by 1197
Abstract
The immunopathogenesis of HS is partially understood and exhibits features of an autoinflammatory disease; it is associated with the potential involvement of B cells and the contribution of Th1 or Th17 cell subsets. Recently, the pathogenic role of both innate immunity and IL-1 [...] Read more.
The immunopathogenesis of HS is partially understood and exhibits features of an autoinflammatory disease; it is associated with the potential involvement of B cells and the contribution of Th1 or Th17 cell subsets. Recently, the pathogenic role of both innate immunity and IL-1 family cytokines in HS has been deeply investigated. Several agents targeting the IL-1 family pathway at different levels are currently available and under investigation for the treatment of HS. HS is still characterized by unmet clinical needs and represents an expanding field in the current scientific research. The aim of this narrative review is to describe the pathological dysregulation of IL-1 family members in HS and to provide an update on therapeutic strategies targeting IL-1 family cytokine signaling. Further clinical and preclinical data may likely lead to the enrichment of the therapeutic armamentarium of HS with IL-1 family cytokine antagonists. Full article
(This article belongs to the Special Issue Novel Insights into Autoimmune/Autoinflammatory Skin Diseases)
Show Figures

Figure 1

Back to TopTop